Biomarin Pharmaceutical Inc (BMRN) — Cash Flow Reinvestment Rate
Biomarin Pharmaceutical Inc (BMRN) has a Cash Flow Reinvestment Rate of 3.46x as of March 2026, reinvesting $762.41 Million (capex $20.92 Million plus investments $741.49 Million) from operating cash flow of $220.65 Million. Check cash flow quality index of Biomarin Pharmaceutical Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Biomarin Pharmaceutical Inc Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Biomarin Pharmaceutical Inc across 12 annual periods. Explore Biomarin Pharmaceutical Inc (BMRN) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Biomarin Pharmaceutical Inc (2009–2025)
Year-by-year capital reinvestment analysis for Biomarin Pharmaceutical Inc. For live market cap and broader valuation context, see BMRN stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.15x | $121.11 Million | $827.99 Million | $103.04 Million | ▼ -64.2% |
| 2024 | 0.41x | $233.91 Million | $572.84 Million | $97.42 Million | ▼ -67.1% |
| 2023 | 1.24x | $197.68 Million | $159.26 Million | $96.69 Million | ▲ +54.9% |
| 2022 | 0.80x | $140.99 Million | $175.90 Million | $120.96 Million | ▼ -49.7% |
| 2021 | 1.59x | $485.54 Million | $304.54 Million | $119.22 Million | ▼ -16.9% |
| 2020 | 1.92x | $163.69 Million | $85.36 Million | $137.52 Million | ▼ -63.5% |
| 2019 | 5.25x | $253.21 Million | $48.26 Million | $145.03 Million | ▼ -78.9% |
| 2018 | 24.92x | $503.60 Million | $20.21 Million | $144.62 Million | ▲ +124.3% |
| 2012 | 11.11x | $195.65 Million | $17.61 Million | $44.57 Million | ▼ -4.8% |
| 2011 | 11.67x | $218.88 Million | $18.75 Million | $154.22 Million | ▲ +219.9% |
| 2010 | 3.65x | $68.39 Million | $18.75 Million | $49.46 Million | ▲ +256.4% |
| 2009 | 1.02x | $89.80 Million | $87.73 Million | $89.80 Million | — |